| Role |
Name |
Disclosure |
Details |
| Author | Stephanie L Lee, MD, PhD, FACE, Director of Thyroid Disease Center, Department of Medicine, Associate Professor, Boston Medical Center, Boston University School of Medicine | Nothing to disclose | Details | | Coauthor | Sonia Ananthakrishnan, MD, Fellow in Endocrinology, Department of Medicine, Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center | Nothing to disclose | Details | | Medical Editor | Frederick H Ziel, MD, Chief of Endocrinology, Kaiser Permanente Woodland Hills, Associate Professor, Department of Internal Medicine, Division of Diabetes and Endocrinology, University of California at Los Angeles | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Yoram Shenker, MD, Chief of Endocrinology Section, VA Hospital of Madison, Section of Endocrinology, Diabetes and Metabolism, Interim Chief, Associate Professor, Department of Internal Medicine, University of Wisconsin at Madison | Nothing to disclose | Details | | CME Editor | Mark Cooper, MD, Head, Vascular Division, Baker Medical Research Institute; Professor of Medicine, Monash University | Nothing to disclose | Details | | Chief Editor | George T Griffing, MD, Professor of Medicine, Director of General Internal Medicine, St Louis University | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Sonia Ananthakrishnan, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Frederick H Ziel, Medical Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Yoram Shenker, Managing Editor |
The contributor discloses no conflict of interest. |
|